Wilson Therapeutics

Wilson Therapeutics

Verified
Developing novel treatments for Wilson Disease

Launch date
Employees
Market cap
-
Net debt
-
Firm valuation
$855m (Public information from Apr 2018)
Stockholm Stockholm County (HQ)

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues--<1m700m776m--
% growth---349900 %11 %--
EBITDA--(40m)600m---
% EBITDA margin--(20000 %)86 %---

Source: Company fillings or news article, Dealroom estimates

  • Edit
DateInvestorsAmountRound
€36mSeries B
N/A€46.9m
Valuation: €136m
IPO
N/ASEK244mPost IPO Equity
$855m
Valuation: $855m
Acquisition
Total Funding$39.6m

Recent News about Wilson Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.